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IMPLEMENTATION OF MICROFLUIDIC MIXERS FOR THE OPTIMIZATION OF

POLYMERIC, GOLD, AND PEROVSKITE NANOMATERIALS SYNTHESIS
ALEXA ROBERTS

ABSTRACT
Nanoparticles have a wide range of applications in biomedicine, catalysis, energy,

semiconductors, and consumer products, to name a few. Conventionally, batch synthesis
of a variety of nanoparticles is achieved using bottom-up (e.g., wet methods, nucleatedgrowth, microbial synthesis) or top-down (e.g., milling) approaches. However, the

reactions, especially in bottom-up approaches, could be time and resource intensive when

optimizing for the effects of reaction parameters and their interplay on nanoparticle
characteristics and purity. Microfluidic platforms could help overcome these limitations by
enabling high-throughput reactions, combinatorial approaches, in situ monitoring
capabilities, and utilizing fewer reactant volumes. The aim of this study is to optimize the

synthesis of three different types of nanomaterials: poly-lactic-co-glycolic acid (PLGA)

nanoparticles, gold (AuNPs) nanoparticles, and lead iodide perovskite nanoplatelets
(PNPs), using two types of microfluidic mixers: the reverse staggered herringbone (SHB)

mixer and S-shaped Dean mixers. The effect of variables such as the inlet flowrate into the
device ports, reactant compositions and mole ratios, and mixer type was investigated to
identify the optimal synthesis conditions, i.e., the conditions leading to narrow and uniform
size distributions, for each type of nanomaterial in these micromixers. The outcomes from

these microfluidic mixers were compared to their counterparts from batch synthesis. Future
studies could test the applications of such nanoparticles in targeted imaging and drug
encapsulation.
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CHAPTER I

INTRODUCTION

1.1 Nanoparticles

Over the past few decades, nanoparticulate systems have been of immense interest
due to their utility as a physical platform to improve the pharmacokinetic properties of

various types of drugs (Mohanraj and Chen, 2006). These nanoscale dimensions confer a

large surface area to volume ratio, thereby giving them very specific and unique properties.
Nanotechnology has had a huge impact on drug delivery systems, and helped achieve many

possibilities such as improved delivery of poorly water-soluble drugs (Bunjes, 2010),

targeted delivery in a cell or tissue specific manner, delivery of macromolecule drugs to
intracellular action sites, exhibiting stealth properties capable of evading immune

responses (Gad et al., 2016), and real-time imaging of in vivo efficacy of therapeutic agents

(Farokhzad and Langer, 2009). For example, biodegradable polymeric nanoparticles have

been used as potential drug delivery devises because they can act as carriers of DNA in
gene therapy (Menon et al., 2014) as well as circulate for prolonged periods to target a
specific tissue or organ.
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A crucial parameter in nanoparticle synthesis is their size, with particles between
10 nm to 200 nm being the most relevant and sought after for biochemical targeting via
intra-vascular and site-specific deliveries (Hickey et al., 2015). Other key goals in

designing an efficient delivery system include control on surface properties (Verma and
Stellacci, 2010) and controlled release of pharmacologically active agents (Lammers et al.,
2011) to achieve the site-specific action of the drug at the optimal dose and rate. This

however requires a tighter control on the reaction or synthesis conditions leading to
desirable average particle size and a narrow size distribution. For instance, this is critical

for applications in fluorescent probes that can emit narrow light in a wide range of
wavelengths (Salata, 2004).

1.2 Synthesis Methods and Mixing Types
Unfortunately, precise control over the operating conditions of any nanomaterial is
limited under batch synthesis methods, at times leading to impurities, failed reactions,

broad particulate sizes, and undesirable product. This necessitates further purification,
filtration or sieving steps to obtain the desired product characteristics. For instance, a study
by Srihari et al. analyzed the synthesis of zinc oxide (ZnO) nanoparticles via batch mode.

ZnO nanoparticles have been studied due to their large bandwidth and high excitation
binding energies and its potential in applications that include antioxidant, wound-healing,

and antibacterial properties (Jiang et al., 2018). Although the room temperature wet
chemical method was adopted for synthesis, there were many limitations on the industrial
scale due to long mixing cycles and therefore uncontrolled growth and nucleation of the

nanoparticles (Srihari, 2017). Their study also detailed other noticeable issues including
non-uniformity of the temperature throughout the reactor and inconsistent flow rates that
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eventually led to a wider particle size distribution. The non-continuous synthesis performed
in this case furthermore caused variations in the nanoparticles from batch to batch and had

low reproducibility, leading to non-ideal operating conditions for future experiments and

studies (Srihari, 2017).
One potential solution to these disadvantages is introducing continuous-flow

synthesis, either in bulk or at a microscopic level, over the conventional batch synthesis

mode. Previous studies showed that complications in batch processes associated with largescale transport and storage as well as health and safety issues are significantly minimized
in microscale reactors such as microfluidic mixers (Song et al., 2008). Such microfluidic

mixers involve the manipulation of fluids within channels that have inner dimensions
smaller than one millimeter (Novotny and Foret, 2016), which causes the surface area to

volume ratio to increase by a few orders of magnitude. Combining nanoparticles and
microfluidics as a drug delivery system leads to easy manipulation to achieve both passive

and active drug targeting and sustained release of the drug during the transportation and at
the site of localization (Mohanraj and Chen, 2006).

The various methods of mixing on a microfluidic level can be classified as either
active or passive mixing. Active mixers involve a type of external source that assists in

agitating the fluid; for example, in the form of mechanical pulsation or electrokinetic forces
(Niu et al., 2006). Although active mixers have versatile functionalities due to the
adjustment of parameters such as frequency, amplitude, and phase, only a few studies have

been conducted due to the complexity of control schemes and difficulty in fabrication
especially on the microscale (Niu et al., 2006). More commonly, passive mixers tend to be

favored in real applications and revolve around the idea that fluid flow perturbations are
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caused by geometric obstacles. Passive mixers therefore utilize no energy input other than
the pressure head, which drives the fluid flow at a constant rate (Lee et al., 2015).

Compared to their traditional macroscale counterparts, passive mixers have a shorter
operation time, more portability, reduced cost and external power requirement, and more
straightforward integration that can be utilized for a diverse range of high-performance

microfluidic applications (Lee et al., 2015).

Microfluidic scale synthesis enables incorporating ideal conditions and variables
such as rapid mixing (Valencia et al., 2010), mass transfer between phases (Cabeza et al.,
2016), temperature control enabling reactions (Miralles et al., 2013), and residence time

control (Shin et al., 2020). To elaborate on this control, the process overall becomes more
efficient in terms of the electrochemical reactions and the ability to obtain a homogeneous

solution as a product (Srihari, 2017). For example, in liposome synthesis, it has been shown
that a microfluidic approach generates a narrower size distribution when smaller liposomes
are desired (Jahn et al., 2008).

Additionally, microfluidic synthesis offers important benefits involving the size
and cost of the process and the overall safety of the process in terms of handling potentially
hazardous reagents. Since batch synthesis is a space-resolved process, large vessels require

higher outputs in the reaction and significantly increase the cost of materials and time,

which is resolved using, for example, continuous flow micromixers. Furthermore,
relatively small volumes of flow reactors reduce the possibility of unsafe side (or runaway)
reactions getting out of control as well as the damage to any equipment or operator (Srihari,

2017). These characteristics of microfluidic systems therefore offer solutions to the
synthesis of nanomedicines with a high-throughput approach (Huang et al., 2020) to
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improve control of the reaction parameters as well as the reproducibility of the experiments
(Jamal et al., 2011).

The future work of microfluidic synthesis of nanomaterials and their applications

involves the scale-up production of nanoparticles. The main goal of scaling up these
experiments is to increase the output of the overall process. A major challenge in scaling

up these experiments is the high possibility that the heat and mass transfer rates could be
altered, thereby leading to different regimes for the nucleation and growth of the
nanoparticles (Tighe et al., 2013). This could furthermore lead to altered properties such as
size distribution and phase purity and may therefore be undesirable for their intended

applications. One option for scaling up is by parallelization, which can be achieved by
placing multiple mixers in parallel so that the production rate can be directly multiplied

with the same properties as those prepared at a bench-scale. This method involves selective

dimension enlargement with the microfluidic channel size being increased so that the

throughput could also be increased (Webb et al., 2020). Another promising method for
rapid synthesis, for example of nanoceramics, is continuous hydrothermal flow synthesis

(CHFS), which utilizes a feed of low-density supercritical water mixing with a higher

density ambient temperature flow of aqueous metal salts into a confined jet mixer to rapidly
convert the metal salts into metal oxide nanoparticles (Tighe et al., 2013).

1.3 Synthesis of Various Nanomaterials

Besides the ZnO nanoparticles mentioned above, gold nanoparticles (AuNP) are of
significant prominence due to their intriguing size-and-shape dependent physiochemical

properties, biocompatibility (Wu et al., 2018), ease of functionalization (Conde et al.,
2010), and non-toxicity (Rahman and Rebrov, 2014). Gold-based nanoparticles are also
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the main mediators of photothermal therapy applications because they offer small

diameters that enable tumor penetration upon system delivery, efficient light to heat
conversion, and the ability to be tuned to absorb near-infrared light (Riley and Day, 2017).

The AuNP reaction mechanism utilizes the Turkevich method, which plays an important

role on the properties of the nanoparticles that are produced (see Appendix A for

Turkevich method on AuNP reaction mechanism). The gold atom in the precursor is
surrounded by four chloride ions, creating a strong acidic environment. These chloride ions
are exchanged with hydroxide ions as the pH is increased, providing the opportunity or

more than one gold species to be present in the reactant prior to synthesis. Temperature
also plays a role in this relationship, as it increased the rate of hydroxylation. This
hydroxylated species has less redox potential than the chloride surrounded species and

therefore results in less gold precursor being reduced by the sodium citrate. Finally, the

chemistry of the sodium citrate reducing agent plays a role in the AuNP properties, as it

exists in equilibrium with different species. The citrate contains three carboxyl groups that
result in an acid/base buffer, with low pH values favoring the protonated species rendering
the molecule less active. Furthermore, the protonated form will no longer be negatively

charged thereby reducing the overall repulsive forces. These properties of the reactant
chemistry plays an important role in how the seed particles form and grow (Wuithschick

et al., 2015).
Wagner reported AuNP synthesis in a microfluidic microreactor chip that consisted

of two micromixers (Figure 1): the first contained ascorbic acid and the second contained
the gold seeds where there was an added chloroauric acid input so that the flow rate ranged

from 5-50 uf (Wagner et al., 2004). The trend in the resulting gold nanoparticles showed
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that as the flow rate increased, the mean diameter of the gold nanoparticles decreased while
the total number of nanoparticles increased. The obtained product also showed a smaller
polydispersity index as well as a size distribution twice as narrow in comparison to the

batch synthesis method counterpart (Wagner et al., 2004). Others have discussed how
multiphase microreactors show promise in synthesizing AuNP with high monodispersity

within short timescales (Rahman and Rebrov, 2014).

Figure 1: Microfluidic chip consisting of two micromixers, used for gold nanoparticle
synthesis. Reproduced by Wagner et. al.

A study conducted by Lim et al. discussed parallel microfluidic synthesis of sizetunable polymeric nanoparticles using 3D flow focusing (Lim et al., 2014). One of the most

studied polymers is the United States Food and Drug Administration (FDA) approved polylactic-co-glycolic acid (PLGA) (Rieux et al., 2011), due to its ability to biodegrade, elicit

almost no immunological response, and self-assemble into nanometric micelles that are
able to entrap small drug molecules (Locatelli and Franchini, 2012). These nanoparticles
form from an oil-water emulsion method in order to encapsulate hydrophobic and

hydrophilic drugs. This method involves the PLGA being dissolved into an organic phase
that is emulsified with a surfactant. Hydrophobic drugs can then be directly added to the

oil phase, whereas the hydrophilic drugs may be first emulsified with the polymer solution
prior to nanoparticle formation (McCall and Sirianni, 2013).
7

A multilayer, 3D hydrodynamic flow focusing microfluidic device was utilized to

introduce acetonitrile (the organic solvent) with distilled (DI) water, which were employed
as vertical and lateral sheath streams, while the PLGA-PEG precursor was introduced to

the microchannel connected to the middle of the interconnections (Figure 2). The resulting

nanoparticles ranged in size from 13 nm to 150 nm, when the PLGA block length was

varied from 10 kDa to 95 kDa and the organic solution concentration varied between 10
mg/mL to 50 mg/mL (Lim et al., 2014). Their study showed that the 3D hydrodynamic

flow focusing (HFF) device provided more homogeneous nanoparticles compared to batch
synthesis counterpart. Additionally, the advantages of the HFF included enabling the
synthesis of small nanoparticles with high production rates, and could likely be a valuable

tool in pre-clinical in vivo studies (Lim et al., 2014).

Figure 2: Illustration of 3D HFF microfluidic mixer. Reproduced by Lim et al.

Weidman et al. reported for the first time on the highly tunable synthesis of

colloidal perovskite nanoplatelets and their promise as a class of semiconductor
nanomaterials. Specifically, they synthesized lead iodide perovskites with high optical
absorption coefficients, optimal bandgaps, long diffusion lengths (Ma et al., 2016), as well
as good electrical transport properties (Ha et al., 2014). The bulk perovskite unit cell has

the formula ABX3, where A is a cation with a +1 oxidation state, B is a metal with a +2
8

oxidation state, and X is a halide with a -1 oxidation state, and is described by the formula
L2[ABX3]n-1BX4. Here, n represents the number of metal halide octahedra layers present
in the nanoplatelet, with the focus on the batch synthesis of n=1 and n=2 platelets through

the nonsolvent crystallization method (Weidman et al., 2016). The resulting nanoparticles
were analyzed by transmission electron microscopy (TEM), and results showed

nanoplatelets with lateral dimensions between 100 nm and 1 pm. The flexible nature of the
synthesis yielded smaller products in the shape of rectangles with rounded corners. The

study additionally showed how the flexibility in each component of the nanoplatelet
allowed for modification of the absorption and emission energies spanning from the visible

range of the spectrum into the UV range with excellent specificity (Weidman et al., 2016).
Their study showed how n=1 and n=2 perovskite nanoplatelets showed a highly tunable
material system with improved flexibility over their bulk counterparts, although future

studies should address the challenges related to large-scale synthesis (Weidman et al.,

2016).
While a variety of these nanoparticles were obtained using batch approaches (e.g.,
wet or hydrothermal synthesis), it remains yet to be elucidated whether they can be

synthesized with high fidelity using microfluidic platforms. Even if so, what are the optimal
synthesis conditions? What type of microfluidic mixers are appropriate? What would be
the resultant particle sizes and their distributions? How do the results compare to their batch

synthesis counterparts? Several such questions remain unanswered and guide the
objectives of this work.
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1.4 Microfluidic Mixers
In this work, to synthesize the AuNP, PLGA nanoparticles, and lead perovskite

nanoplatelets, two microfluidic devices were implemented in a high-throughput fashion to

analyze their relative advantages. PDMS was chosen as the material for the microfluidic
devices because it offers rapid prototyping (Karadimitriou et al., 2013), low cost, and can
easily bond to different substrates (Wang et al., 2014). Besides, our lab has extensive

background and expertise in the design, fabrication, and implementation of these devices,

in collaboration with Dr. Petru Fodor’s group (Sarsfield et al., 2021; Rhoades et al., 2020;

Clark et al., 2019; Hama et al., 2018; Clark et al., 2018). The fabrication protocol of these
microfluidic devices was detailed in Appendix B.

The first microfluidic device used in this study is a reverse staggered herringbone

(SHB) mixer, developed by Brian Hama (Hama et al., 2017), which was used primarily as
the microfluidic platform for PLGA nanoparticle synthesis. The assumptions made on the

device itself include operation at steady state conditions, room temperature of 25 °C and
pressure at 1 atm, and oriented in such a way that all mixing channels are at the same

elevation, so that hydrostatic effects are negligible.
Figure 3 shows a closed view of the first mixing cycle in Hama’s optimized SHB
device, with a defined Cartesian coordinate system where the direction of fluid flow in the

channel is x, the vertical direction between the main channel and ridges is y, and the

horizontal direction from the start to end of the channels is z. Each mixing cycle is
characterized by a section of grooves with a shorter left-hand-side followed by a section of

grooves with a shorter right-hand-side. Hama’s work concluded that uniform, efficient
mixing was achieved by the end of three cycles. However, the complete mixer layout
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contained nine complete cycles per straight pass in the main channel, totaling 486 cycles
in the device. Due to the sub-millimeter dimensions in the channel geometry, the

microfluidic flow was characterized as laminar with the Reynold’s number less than 100.

A two-dimensional view of the device is shown below (Figure 3), including two inlet ports,
one outlet port, and optional sensor ports for probing sensible conditions in the flow.

The other microfluidic mixers used in this study are referred to as Dean mixers,

which were primarily implemented for lead iodide perovskite nanoplatelet synthesis as well
as in gold nanoparticle synthesis. These types of mixers have a serpentine design and vary

based on total mixing cycles (in this case 4 or 5) and the shape of their cross section
(rectangular versus non-rectangular). The dean devices with the non-rectangular cross
sections are therefore referred to as Modified Dean (MD) mixers (Figure 5). Figure 6

shows an up-close view of these differences and details the specific characteristics of each
of the four types (Clark et al., 2019).
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Figure 3: The first mixing cycle and channel design of the reverse SHB from A) a closed
diagonal view, B) a view from the xz plane, C) a view from xy plane, and D) a view from
the yz plane. Image courtesy: Brian Hama, CSU Master’s student, Dr. Kothapalli lab.
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Figure 4: Complete schematic of a reverse SHB microfluidic device, including channel
layout. The two arrows on the bottom left hand side of the image represent the inlet ports.
For these experiments, the Sensor 2 port was used as the outlet, as the polymeric
nanoparticles were proven to have sufficiently formed after this time. Image courtesy:
Brian Hama, CSU Master’s student, Dr. Kothapalli lab.
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Mixing unit
Figure 5: Close ups of the channels in each of the two types of dean mixers. The right
image details a mixing section for a Dean mixer containing rectangular cross sections,
while the left image details a mixing section for a Modified Dean mixer with nonrectangular cross sections.
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Figure 6: Schematic of each type of Dean Mixers used in the experiments, and specific
details of each. Starting from the top and going clockwise: Dean 4 (D4), Modified Dean 5
(MD5), Dean 5 (D5), and Modified Dean 4 (MD4). Produced by Ben Bosela, a REU
summer student in Dr. Kothapalli’s lab.

The objective of this work is to investigate the synthesis of the three types of
nanomaterials mentioned above using these microfluidic platforms. The optimal operating
conditions of each type of nanomaterial synthesis were explored by varying parameters

such as total flowrate of reactants into the device, reactant compositions and molar ratios,
device geometry, and mixer type. The obtained synthesis products were characterized using

a scanning electron microscopy (SEM), energy dispersive x-ray spectroscopy (EDS),
dynamic light scattering (DLS), and nanospectralizer, and compared to their counterparts
from batch synthesis protocols (either in this study or from literature).

15

CHAPTER II

MATERIALS AND METHODS

2.1 Preparation of Reagents
2.1.1 Organic Polymer Solution
The three materials used in the PLGA nanoparticle synthesis were deionized water,
PLGA, and acetonitrile. The first syringe contained 12 mL of deionized water that had been

autoclaved. For the second syringe, the PLGA (Polysciences) was dissolved in acetonitrile

(Sigma Aldrich, CAS Number: 75-05-8) to form an organic polymer solution. PLGA was
chosen over others such as PLLA due to its additional control over degradation rates and
lower glass transition temperature. The specific properties of the PLGA chosen for these
experiments include an inherent viscosity of 0.4 dL/g, a 50:50 lactide to glycolide mole

percent ratio, and a molecular weight of ~ 19 kDa. Although many organic solvents could

be utilized in PLGA nanoparticle synthesis, acetonitrile was chosen since it is compatible

with the PDMS used to fabricate the microfluidic devices. The concentration ratio and inlet
flow rate were the two control variables in these experiments and varied according to Table
1.
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Table 1: Design of experiments for PLGA nanoparticle synthesis.

Product

Concentration Flow rate

name

ratio (wt%)

(uL/min)

P2

0.25

70

P3

0.20

70

P4

0.15

70

P5

0.10

90

P6

0.10

70

P7

0.10

50

Once the desired amount of PLGA polymer was mixed and thoroughly dissolved
into the acetonitrile, 10 mL was taken into the syringe. Since the first syringe had more

volume, it was placed into the PicoPlus pump, while the second syringe was placed into
the Razel pump. More details on these pumps and their calibration could be found in

Appendix C.

2.1.2 Gold Chloride and Sodium Citrate Solutions Formulation
For synthesis of the gold nanoparticles, the two solutions utilized were gold

chloride and sodium citrate. A bulk solution of 0.1 mg/mL gold chloride was formulated
for these experiments. The first syringe contained the appropriate amount of gold (III)

chloride trihydrate (Sigma Aldrich 520918) thoroughly mixed with DI water, resulting in
an intrinsic pH ~ 3. The microfluidic runs contained 10 mL of solution that was prepared
from the bulk by pH adjustment with 1 N sodium hydroxide (Sigma Aldrich). Similarly, a

10 mg/mL bulk solution of sodium citrate dihydrate was formulated by mixing it with DI

water. The conditions of these experiments included inlet flow rates of 50 uL/min operating
at room temperature, while the architecture of the micromixer was varied. This syringe also
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contained 10 mL of solution for each microfluidic run. Additional information regarding
the gold nanoparticle growth mechanism and stability can be found in Appendix A.

2.1.3 Precursor Fluids for Perovskite Synthesis

Synthesizing perovskite nanoplatelets (PNP) begins with dissolving precursor salts
in DMF in the optimal concentration ratios. The most efficient way to achieve this is to

create three DMF solutions of each molarity (for each salt). The bright yellow 0.55 M lead

iodide solution in DMF comes pre-made from Sigma Aldrich. The 0.55 M pale green
butylammonium iodide solution and the 0.55 M clear formamidinium iodide solution were

formulated by dissolving the respective salts in DMF in the ratios listed in the Table 2,
shown below.

Table 2: Instructions for dissolving salts in DMF to form the precursor fluids for PNP
synthesis.
Sample
Butylammonium Iodide
Formamidinium Iodide

Molecular Weight
(g/mol)
201.05
171.97

Amount (g) added to 1 mL
DMF to achieve 0.55 M
0.1106
0.0946

2.1.4 Batch Synthesis of PNPs: Non-Solvent Crystallization
The method used in batch synthesis of perovskite nanoplatelets is known as non
solvent crystallization. This process first involves the stock solution being formulated by

dissolving precursor salts AX, BX2 and LX in correct ratios in dimethylformamide (DMF)

at a concentration of 0.1 M (Weidman et al., 2016). For these experiments, L indicates
butylammonium, A is formamidinium, B is lead, and X is iodide, so that the result is lead

iodide perovskite nanoplatelets. The stock solutions were then mixed in proper portions
resulting in n=1 or n=2 nanoplatelets. In following the perovskite unit cell formula, the

stoichiometry calls for a 2:1:0 ratio of LX:BX2:AX for n=1 nanoplatelets, and a ratio of
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2:2:1 for n=2 nanoplatelets. Once approximately 10 ^L of any of the precursor solutions
were made, they could be added dropwise to approximately 10 mL of toluene (depending
on the volume ratio being tested) at room temperature and shaken vigorously for 10

seconds to ensure homogeneity in the product solution. Since DMF and toluene are

miscible but none of the precursor salts are soluble in toluene, the salts are therefore forced
to recrystallize and form this perovskite crystal structure (Weidman et al., 2016).

Successful synthesis resulted in a bright orange colored solution for n=1 nanoplatelets and

a bright red solution for n=2 nanoplatelets, while unsuccessful synthesis resulted in a pale
yellow color with a feather like consistency, as shown in Figure 7.

Figure 7: A) Representative image of an unsuccessful batch synthesis of PNPs. B)
Illustration of a successful batch synthesis with typical color noticed for n=1 and n=2
perovskite nanoplatelets.

2.2 Experimental Setup for Microfluidic Mixer Based Synthesis
The first part in setting up this experiment involved loading the two fluids into the
syringes. Once both fluids were in the syringe delivery setup and cleared of all air bubbles,
they were inserted into two separate pumps (Harvard Instruments PicoPlus, Catalog No.

70-2213; Razel Model No. A-99 FM). The pumps, previously calibrated by Brian Hama,
allowed for operation of flow rates between 5 DL/min and 500 DL/min.
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The experiment took place under a fume hood. The microfluidic device was placed

on an elevated plate for the sole purpose of propping it up to the height of the pumps. All
pipette tips were inserted into their desired ports (two inlets from the syringe delivery

system fabrication, one outlet tubing). Details of the fabrication of the syringe delivery
system can be found in Appendix C. The outlet tubing led from the device into a glass test
tube that was placed in a test tube holder. From there, all connections in the system were

secured. The pumps were set to their appropriate settings based on the desired flow rate
and turned on simultaneously. It took the system approximately three minutes to equilibrate
the pressure; therefore, the first 3-5 minutes of product was discarded to account for uneven

mixing.

Figure 8: Illustration of nanoparticle synthesis in the reverse SHB microfluidic mixer. The
two pipette tips on the right side of the image represent the organic solution and DI water
at the inlet ports of the reverse SHB device. The precipitated solution shown in the left side
pipette tip of the image shows that the PLGA nanoparticles have been synthesized and are
being collected in the outlet tubing.
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Figure 9: Illustration of nanoparticle synthesis in the Dean 4 type microfluidic device. A)
The toluene and precursor fluids are shown at the inlets on the right side of the image,
while the orange colored solution in the left side pipette tip shows the successful synthesis
of platelets of n=1 thickness in the outlet tubing. B) Similarly, the toluene and precursor
solutions enter the Dean 4 device at the inlets, and the bright red product in the outlet
tubing confirms the successful synthesis of platelets of n=2 thickness. Image courtesy:
Quinton Wright, NSF REU summer student, Dr. Kothapalli lab.
The process was stopped once at least 2 mL of the product (containing polymeric
nanoparticles) solution was collected. All equipment was flushed, and the remaining
solutions were discarded into a liquid organic waste container. Appendix C shows a full
illustration of the experimental setup from a top-down view. Figures 8 and 9, respectively,

illustrate the experimental setup leading to successful synthesis of nanoparticles in the
reverse SHB device and the Dean mixer.

2.3 Characterization Techniques
2.3.1 Scanning Electron Microscopy (SEM)
The scanning electron microscope (Field Emission SEM; FEI Company Model:
Inspect F50) analyzes the shape of the nanoparticles by means of qualitative analysis. This
characterization method involves an electron beam hitting the conductive surface of the
sample and allowing the electrons to scatter in such a way that a detector inside of the
vacuum chamber produces a clear image of the nanoparticles in the sample. SEM operating
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conditions such as magnification, focus, brightness and contrast, and beam, stage, and

scanning parameters were adjusted according to the size and sensitivity of all samples and
was determined using a trial and error type method. Since the samples in this study were
on the nanoscale and very thin, the optimal beam current was set at a lower value of 5 kV,
and the scanning parameter was set to a slower speed of 30 us to obtain a higher quality

image for each type of nanomaterial tested. The size of the particles was then measured

manually by drawing a line across each particle to determine a numerical value for the
diameter. This results in reasonably precise measurements, but potential errors in accuracy
could arise due to subjectivity.

Each type of nanoparticle product was taken for sample preparation immediately
after the desired amount of product was collected from microfluidic platform or batch
synthesis runs. To ensure that the sample could safely and securely be placed in the SEM

chamber, it needed to adhere to a type of conductive chip and then placed onto an aluminum

plate that fit directly into the microscope. The first step involved utilizing a plasma cleaner
to treat the surface of a silicon chip. After about 20 minutes in the plasma chamber, the

cleaned chip was transferred onto a piece of double sided-carbon tape that is attached to
the aluminum plate. From there, 1 L of sample is immediately pipetted to the center of
the silicon chip and remained there to dry (~ 1 h) until all the solvent had evaporated. Since
the SEM works on conductive surfaces, the gold and lead iodide samples are now ready to

enter the microscope. In the case of the PLGA nanoparticles, silver epoxy was applied to
two opposing corners of the silicon chip to obtain the desired conductivity of the sample.

Once the silver was completely dried on both the silicon chip and aluminum plate, it was
placed in the SEM chamber for analysis.
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2.3.2 Energy Dispersive Spectroscopy
Energy dispersive spectroscopy (EDS) is a technique used to analyze the elemental

composition of various types of conductive samples. The EDS detector (Model 51-

XMX1005) used in these experiments is an Oxfords Instruments X-Max 80 mm2 area solid

state detector using liquid nitrogen-free Peltier cooling. The range of detection is from
beryllium to plutonium, with a peak resolution guaranteed to change less than 1 eV between

1-100 thousand counts per second. The system uses an INCA-stream 2 pulse detector and
the INCA Energy IE350 analysis software (Oxford Instruments). A Point & ID approach

was used in the INCA software with guided steps to report the findings. Once the sample
was acquired, the site of interest can be identified for the machine to analyze, and then the
spectra is acquired within five minutes. After the analysis has been run, the user can

confirm which elements they want to quantify in the final EDS report. From these studies,
the captured SEM site of interest, the full spectra, and the quantitative results could be

displayed.

EDS was used to determine the thickness of nanoplatelets obtained from various
experimental procedures. The nanoplatelet formula is thickness dependent, therefore every
nanoplatelet has a unique lead to iodine ratio that is determined using the common platelet

formula listed in Chapter 1. PNPs of n = 1 thickness have a 1:4 lead to iodine ratio, whereas
PNPs of n = 2 thickness have a 2:7 lead to iodine ratio, and bulk perovskite has a 1:3 lead

to iodine ratio. EDS was performed on highly concentrated areas of nanoplatelets and the

lead: iodine ratio determined.
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2.3.3 Dynamic Light Scattering

Dynamic light scattering (DLS) technique was used to quantify the average particle
size and distribution of the resulting nanoparticles. DLS experiments were performed using
an Ar+ Spectra Physics 2017 laser (Brookhaven Instruments) setup with BI-900 correlator,

BI-DS2 photomultiplier, and BI-200SM goniometer. The laser power was controlled using

a TSX-1A variable neutral density filter (ORIEL) and a VPH-4 optical iris (NRC). In this
study, the decay rate of correlation function was plotted as a function of angle

measurements (70° to 120°), where the slope of each line denotes the diffusion coefficient.

The measured intensity-intensity correlation data was analyzed in two ways: with a

CONTIN algorithm (Provencher) which provided a smoothed inverse Laplace transform
to yield particle size distribution and fit at the level of the field-field correlation function
to a stretched exponential to determine the average particle size using spectral time moment
analysis (Streletzky et al., 2008). Additionally, DLS assumes that all particles in the

solution are of spherical shape, which could be a likely cause for error in this analysis
technique if the particles we analyze are not spherical. Furthermore, the spectral time
moment analysis results in a stretching parameter p that relates to the width of particle size

distribution or sample polydispersity. A value of p closer to one indicates a higher mono
dispersity in the distribution of spherical particles (Sarsfield 2021, Supplemental Section).
Similar to the SEM procedure above, the polymeric nanoparticle samples went

through sample preparation prior to quantification using dynamic light scattering (DLS)

analysis. Once the product had been collected and a small amount has been set aside for

the SEM analysis, the solution was diluted. In this case, two times the amount of product

collected (by volume) was used to determine the amount of 200 proof ethanol (Sigma
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Aldrich) needed for dilution. This was done simply by pipetting the necessary amount of
ethanol into the product test tube, and then immediately covering the new solution with

paraffin wax to prevent solvent evaporation. The diluted polymeric nanoparticle solution

was then taken for DLS analysis.
2.3.4 Spectrometry
The NS3 NanoSpectralyzer (Applied NanoFluorescence LLC) was used to

characterize the lead iodide perovskite nanoplatelets by collecting the optical spectra from
the sample. The NS3 system is a modular multi-mode spectrometer with a base system that

includes NIR emission and absorption with three discrete excitation wavelengths from 405
to 830 nm. The absorption spectra were measured in a single-beam mode using broadband
probing light from a stabilized tungsten-halogen lamp with a 2 mm beam diameter. The

NS3 also captures emission spectra using several discrete excitation wavelengths to
additionally provide an analysis with far higher speed and sensitivity. In these experiments,
visual absorption and emission were recorded on the NS3 with a 408 nm wavelength
excitation, where toluene was used as the reference fluid. The resulting set of fluorescence

spectra was quickly analyzed using a sophisticated firing software to deduce an inventory

of species in the sample and their relative concentrations. These results are then compiled
into tables and graphs.
2.4 . Statistical Analysis

For each type of nanomaterial, the experimental conditions for each trial were
repeated at least 3 times for reproducibility purposes. Each polymeric nanoparticle

condition was independently run and had at least 50 particles characterized (5 times each)
by the SEM analysis, and DLS analysis was performed on three of these occasions. To
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ensure optimal operating conditions, P4 was tested an additional 3 times for confidence in
future studies with drug encapsulation. A separate reverse SHB device was utilized for
each trial and then discarded after at least 3 mL of product was collected. In the case of

gold nanoparticles, each condition was independently run 3 times, with no less than 140
particles being analyzed by the SEM analysis. Similarly, each run was conducted using its
own specific Dean device, and then discarded after product collection. Finally, all the batch

PNP experiments were independently run 5 times and had a minimum of 100 particles
characterized by the SEM per condition, along with the EDS analysis on two instances.

The spectrometry was also used for analysis on five separate occasions. The microfluidic
PNP experiments were conducted 3 independent times and analyzed by SEM for all trials,

and with EDS for two of the trials. A separate D4 device was used for each trial run.
Statistical analysis was conducted using the student’s t-test for quantitative data

comparisons between any two groups.
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CHAPTER III
RESULTS AND DISCUSSION

3.1 Polymeric Nanoparticles
Representative images from the SEM analysis for each operating condition were
shown in Figures 10 and 11, while the corresponding DLS graphs were shown in Figures

12 and 13. A comparison of the average particle size determined by each method was

summarized and the results were shown in Table 2. With the main goal involving the

operating conditions that produce the most uniform particle size distribution, the smallest
deviation in particle diameter was desired. Additionally, the average particle size of DLS

was to be within the deviation range of the SEM to confirm accuracy in the results.
The quantitative analysis was done on the SEM results. For each of the six products,

images were taken at four random locations on the sample: two from the edges of the
nanoparticle residue, and two from the center of the sample. Each image allowed for
roughly 40 nanoparticle sizes to be confidently measured, which were used to determine

the average and standard deviation of the data set. Also shown with this analysis is the size

distribution graphs for each product, which tells whether the data was normally distributed

or skewed. It could be seen that the median size for samples P3, P4, P6 and P7 is lower

than the mean size, which is represented in the skewness of the data distribution. The
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second analysis was done on the DLS results, where three independent trials were
conducted on each condition. Figure 12 presents the linear relationship between the decay

rate of correlation function and the scattered angle measurements (70° to 120°). The slope
of these lines is the diffusion coefficient, and results in a value of the average hydrodynamic
radius of the particles. Another desired characteristic of the nanoparticles considers how

spherical they were in the product solution. The other DLS graph, shown in Figure 13,

demonstrates the polydispersity coefficient as a function of the same angle measurements.
With the exception of P5, all samples showed coefficients above 0.90, meaning that they
all exhibit largely sphere-like behavior.

Figure 10: A) A representative SEM image from P2 and its corresponding size distribution, at
0.25 wt% and 70 UL/min.B) A representative SEM image from P3 and its corresponding size
distribution, at 0.20 wt% and 70 UL/min. C) A representative SEM image from P4 and its
corresponding size distribution, at 0.15 wt% and 70 L/min.
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Figure 11: A) A representative SEM image from P5 and its corresponding size distribution, at
0.10 wt% and 90 UL/min._E) A representative SEM image from P6 and its corresponding size
distribution, at 0.10 wt% and 70 UL/min. F) A representative SEM image from P7 and its
corresponding size distribution, at 0.10 wt% and 50 UL/min.
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Figure 12: The decay rate of correlation functions for five samples from DLS, as a
function of angle measurements 70° to 120°, where the slope of each line denotes the
diffusion coefficient.
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Figure 13: The polydispersity coefficient is shown as a function of the same angle
measurements.

Table 3: Summary of results for the polymeric nanoparticle size measurements.

Product
Name
Mean

(nm)

SEM image analysis
DLS data
St. Dev Standard Median Mean (nm)
Error
64
905.2 N/A
11.14%

(nm)

(nm)

P2

904.6

P3

305.4

30

4.93%

282.5

234.6

P4

254.7

26

4.53%

226.1

359.6

P5

740.2

34

6.31%

775.6

746.6

P6

584.1

44

5.78%

519.7

188.4

P7

718.0

23

4.43%

678.6

237.4
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3.1.1 Effect of Polymer Composition on Particle Size
The polymeric composition of PLGA in the organic solvent acetonitrile was varied
between 0.1 and 0.25 wt%, while the flow rate was held constant at 70 uL/min. In general,

the trend showed that as the polymer concentration was decreased, so did the average
particle size. The dependence of average particle size on the polymer concentration is likely

due to the fact that an increase in concentration will increase the minimum amount of

energy required to complete the reaction and form a nanoparticle, and therefore increase
the diffusion rate in the nanoprecipitation process. Among the P2, P3, and P4 trials that
varied in composition, the results confirmed that the 0.15 wt% of P4 showed the smallest
mean (p < 0.0001), and would be most desirable for reproducibility purposes.

A similar relationship was found in experiments conducted by others, who noted
that the PLGA nanoparticles exhibited a steady increase in size as more concentrated

PLGA was used in the preparation of the organic solution. A study conducted by Huang
and Zhang used a 50:50 PLGA with MW of 30-60 kDa dissolved into polyvinyl alcohol to
synthesize the polymeric nanoparticles via nanoprecipitation. They tested the influence of

polymeric concentration in the organic phase on particle size, varying between 1 and 40

mg/mL, and noted that the nanoparticle size had a linear correlation with polymer

concentration in the 1 -20 mg/mL range (Huang and Zhang, 2017).

Additionally, Feczko et al. demonstrated that PLGA nanoparticles (for drug
delivery applications) having an average particle diameter of 200 nm could be obtained by
the double-emulsion method (Feczko et al., 2011). They used a system of 50:50 wt./wt.

PLGA (MW ~ 8 kDa) dissolved in 5 mL of dichloromethane and concluded that the
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decrease in PLGA concentration in the organic phase caused a considerable reduction in
the resultant nanoparticle size.

3.1.2 Effect of Flowrate on Particle Size
In the next set of experiments, the flow rate of each inlet solution was varied

between 50 ^L/min and 90 ^L/min, while the polymeric composition was held constant at

0.1 wt%. The results showed no significant differences (p > 0.05) in the particle size as the
flow rate decreased. Similar results were found again by Huang and Zhang and stated that
the organic phase injection rate had no effect on the particle size (Huang and Zhang, 2017).

3.1.3 Comparison of Microfluidic synthesis to Batch Synthesis

Finally, we compared the results from these microfluidic experiments to polymeric

nanoparticles synthesized using batch synthesis approaches. No batch synthesis

experiments were conducted in this study, therefore all comparisons to batch synthesis
results were those found in literature. Table 4 shows the quantitative analysis of PLGA
nanoparticles by comparing batch synthesis results to microfluidic results. In general, the
trend across both synthesis methods details how the average particle size of a PLGA

nanoparticle increases with the concentration of polymer in the organic solution. Other
noticeable differences between synthesis methods are present in the size range of

nanoparticles produced, further verifying that a narrower size distribution is obtained from
the microfluidic approach. Additionally, the PDI decreased across all literature when

synthesis occurred on a microfluidic level.

Figure 13 shows the polydispersity coefficient of each condition, with all
conditions besides P5 having a PDI of less than 0.1. Arasoglu reported that PLGA

nanoparticles synthesized on a bulk level via single emulsion solvent evaporation (100 -
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400 mg PLGA dissolved in 1 - 2.5 mL of dichloromethane) resulted in PDI values between
0.1 - 0.2 (Arasoglu et al., 2017). Thus, more spherical and uniform particles synthesized

in the microfluidic level is beneficial for drug encapsulation studies, with less variation in
the release kinetic studies that would follow.

Table 4: Comparison of quantitative results of batch and microfluidic synthesis methods
found in literature for PLGA nanoparticles.
Synthesis Method
(reference)
•

•

•

•

•

•

•

•

Batch
(Arasoglu et al.,
2017)
Batch
(Huang and
Zhang, 2017)
Batch
(Derman, 2015)

Average
particle
size (nm)
183-330

30-400

158-469

Batch
(Feczko et al.,
2011)
Microfluidic
(Xu et al., 2017)

120-220

Microfluidic
(Leung and Shen,
2018)
Microfluidic
(Gdowski et al.,
2018)
Microfluidic
(Karnik et al.,
2008)

30-70

64-109

72-112

20-31

Key observations

Polydispersity index of PLGA nanoparticles
~ 0.217; use of nanoparticle juglone in
biological applications.
As PLGA concentration is increased, so is
the average particle size in a linear
relationship.
Significant increase in particle size with
initial PLGA concentration, with PDI
decreasing as concentration increased.
Decrease in PLGA concentration caused
considerable reduction in the resultant
particle size.
Higher PLGA concentration formed larger
nanoparticles and increase in flowrate
caused smaller size difference between high
and low concentrations.
Microfluidic assisted nanoprecipitation
enabled more narrow particle size
distribution and PDI less than 0.2.
Size of nanoparticles increased as PLGA
concentration increased, with PDI 0.05
0.18.
Average particle size increased as PLGA
content increased, and DLS analysis
revealed larger distribution of 50-300 nm.

Similar results to the microfluidic studies performed in this work were reported by

Karnik et al. in their studies on controlled synthesis of polymeric nanoparticles using a

microfluidic platform (Karnik et al., 2008). Their study detailed hydrodynamic flow
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focusing with the copolymer PLGA-PEG, by varying factors such as polymer
concentration, flow rate ratio, and molecular weight of the copolymers. In the examination

of polymer composition on nanoparticle size, they observed that as the PLGA content
increased to 20% (wt./wt.), the average nanoparticle diameter increased by a factor of 3.5.

Their research additionally confirmed that rapid mixing in a microfluidic device prevented
nanoparticle aggregation, resulting in smaller and more homogeneous particles compared

to that by batch synthesis. Furthermore, they concluded that microfluidics enables control

over the rate of mixing and may be used to tune nanoparticle size, homogeneity, and drug
loading and release (Karnik et al., 2008).

3.2 Gold Nanoparticles Synthesis
Representative images of the SEM analysis for each device type were shown in

Figure 14 along with their corresponding particle size distribution graphs. Additionally, a

comparison of the average particle size determined by each method, summarizing the
results is shown in Table 4. To specifically evaluate the effect of the microfluidic mixer

on the particle size and distribution, the temperature was held constant at room temperature
and the flow rates of each pump in the experimental setup were fixed at 70 uf/min. A

statistical analysis was done to compare the mean, median, and standard deviation resulting
from each of the four devices.
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Figure 14: Representative SEM images and size distributions of AuNPs synthesized using the A) D4 micromixer, B) MD4
micromixer, C) D5 micromixer, and D) MD5 micromixer.
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Table 5: Summary of results for the gold nanoparticle microfluidic synthesis.

Device Type

Mean Standard Standard Median
(nm) Deviation Error (%)
(nm)

Dean 4
Dean 5

23.21
28.36

(nm)
9.61
9.51

0.60
0.68

23.04
26.58

Modified Dean 4 29.18

12.71

1.04

27.25

45.64

19.81

1.67

46.09

Modified Dean 5

3.2.1 Effect of Microfluidic Device Type on Particle Size
The four microfluidic mixers that were used to synthesize the gold nanoparticles
were Dean 4, Dean 5, Modified Dean 4, and Modified Dean 5. The geometry and
dimensions of these devices was detailed in the Introduction chapter. An analysis was done

on each of the mixer responses to compare the significance in differences based on the pvalues obtained from a one-tail test. Overall, when comparing the Dean mixers with
Modified Dean mixers, the results showed that the Dean mixers had led to smaller mean

and median values of particle size (p < 0.0001), as well as the standard deviations, therefore

exhibiting a tighter distribution. Amongst the two Dean mixers, the D4 showed a slightly
smaller mean (p = 0.0003). On the other hand, the MD4 mixer showed a significantly

smaller average particle size (p < 0.0001) and median. There does not seem to be any kind

of obvious trend in the benefit of four versus five mixing cycles; however, four mixing
cycles does prove to be sufficient in successfully synthesizing gold nanoparticles and
requires less time experimentally in terms of product collection. These results suggest that
the conditions of the Dean 4 mixer are most suitable in terms of reproducibility due to their
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smaller size and tighter distribution, which can be beneficial in gold nanoparticle

applications such as biological assays and therapeutics.
Microfluidic synthesis of gold nanoparticles in the reverse SHB device was
investigated and had the same experimental setup as the microfluidic experiments done in

this study (Sarsfield et al., 2018). Furthermore, the quantitative analysis showed an average

particle size ranging from 54 - 79 nm. This range is slightly higher than that obtained from
the Dean mixers, likely because of the large increase in the total number of mixing cycles

that these particles went through in the reverse SHB device. Even though the particles

appeared slightly larger in diameter, the distribution remained within 25 nm from the
largest to smallest nanoparticle. This tighter distribution leads to a more careful

examination of the characteristics of gold nanomaterials and allows for an increase in the
applications of these nanoparticles (Grzelczak et al., 2020).
3.2.2 Comparison of Microfluidic Synthesis to Batch Synthesis
Batch synthesis of gold nanoparticles was not conducted in this study, and

therefore all comparisons to batch synthesis results were with those from literature. Table
6 illustrates the comparison of the quantitative analysis between gold nanoparticles

synthesized via batch methods versus microfluidic methods. The general trend observed
showed a smaller size range among gold nanoparticles synthesized from a microfluidic
device. To elaborate on one literature example detailed above, Silva et al. synthesized gold

nanoparticle composites by adding layered double hydroxides in a solution of gold chloride
on the bulk level. The resulting particles were analyzed by atomic force microscopy (AFM)

and presented a size distribution ranging from 77 - 231 nm, and appeared constituted by

agglomeration of smaller gold crystallites (Silva et al., 2013). The gold nanoparticles
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synthesized on the bulk level have a much broader size range compared to our microfluidic

platform results, which ranged from 23 - 46 nm and a tighter size distribution.

Table 6: Comparison of quantitative results of batch and microfluidic synthesis methods
found in literature for gold nanoparticles.
Synthesis Method

•

•

•

•

•

•

•

•

Batch
(Silva et al.,
2013)
Batch
(Schulz et al.,
2014)
Batch
(Perrault and
Chan, 2009)
Batch
(Personick and
Mirkin, 2013)
Microfluidic
(Cabeza et al.,
2012)
Microfluidic
(Sarsfield et al.,
2019)
Microfluidic
(Luty-Blocho et
al., 2011)
Microfluidic
(Wagner et al.,
2004)

Average
Particle Size
(nm)
77 - 231

Conclusions

AuNPs can be synthesized in the absence
of a classic reducing agent.

8 - 12

Turkevich method yields AuNPs with
improved
dispersity
and
size
reproducibility.
Low concentration of sodium citrate
improved monodispersity and stability of
AuNP.
Seed mediated synthesis allows for a high
degree of shape control and tailorability in
AuNP.
An increase in the residence time was
found to broaden the particle size
distribution.
The concentration ratio showed no
statistical significance on average particle
size.
At higher flow rates, the size of the
AuNPs became smaller.

50 - 175

3-7

3.8 - 4.9

17.5 - 41.4

1-3

3-5

The cluster size can be optimized by
varying flow rate and concentrations.
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3.3 Lead Iodide Perovskite Nanoplatelets
3.3.1 . Spectrophotometry Data
3.3.1.1 . Absorption and emission data for n=1 samples
Both microfluidic and batch synthesis nanoplatelets possess a single absorption
peak between 515 nm and 520 nm. Nanoplatelets synthesized through microfluidics

consistently exhibit narrower emission than their batch counterparts. This was verified
from the full-width half-max values displayed in Figure 16.

Figure 15: A&B) Normalized absorption and emission for n=1 batch synthesis PNPs.
C&D) Normalized absorption and emission for n=1 microfluidic synthesis PNPs.
3.3.1.2 Emission data for n=2 samples
Preliminary results for PNPs (n=2) show that microfluidics synthesis results in a

higher purity of PNPs (n=2) at the same ligand:PNP ratio. However, results for n=2
nanoplatelets were not replicable due to a problem with dilution. When diluted in a 1:20

and 1:40 ratio of PNP product to toluene, a shift towards thicker materials occurred for n=2
and platelets of greater thickness (n > 3), for reasons unknown at this stage. Figures 17

illustrates the n=2 dilution problem.
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Figure 16: A) Emission of n=2 PNPs diluted 20-1 in toluene. B) Emission of n=2 PNPs
diluted 40-1 in toluene.

3.3.2 SEM Images and Analysis
In synthesizing the lead iodide perovskite nanoplatelets, the volume ratio was

varied on the batch synthesis level, while the flow rate ratio was varied for the microfluidic

level experiments, for both n=1 and n=2 platelets synthesis. Figure 18 shows
representative SEM images and size distribution graphs for the three n=1 batch conditions
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tested, for 1:100, 1:80, and 1:65 volume ratio of precursor fluid to toluene. Similarly,
Figure 19 shows the representative SEM images and corresponding size distribution

graphs for the same volume ratios as in the batch synthesis, but for n=2 platelet thickness.
The microfluidic flow rates tested were 1:40 and 1:60 precursor fluid to toluene, for both

n=1 and n=2 platelets, and those were shown in Figures 20 and 21, respectively. Finally,
the various normalized size distribution plots were shown in Figure 22 to compare the
trends between each of the conditions tested. A statistical analysis was conducted on all

batch and microfluidic data collected and is summarized in Table 5.

42

Figure 17: A&B) A representative SEM image from n=1, 1:100 volume ratio and its corresponding size distribution. C&D) A
representative SEM image from n=1, 1:80 volume ratio and its corresponding size distribution. E&F) A representative SEM
image from n=1, 1:65 volume ratio and its corresponding size distribution.
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Figure 18: A&B) A representative SEM image from n=2, 1:100 ratio and its corresponding size distribution. C&D) A
representative SEM image from n=2, 1:80 and its corresponding size distribution. E&F) A representative SEM image from n=2,
1:65 and its corresponding size distribution.
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Figure 19: A&B) A representative SEM image from n=1, 1:40 and its corresponding size
distribution. C&D) A representative SEM image from n=2, 1:40 and its corresponding size
distribution.
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Figure 20: A&B) A representative SEM image from n=1, 1:60 and its corresponding size
distribution. C&D) A representative SEM image from n=2, 1:60 and its corresponding size
distribution.
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Table 7: Summary of results for all batch and microfluidic PNP conditions.
Condition

Mean (nm)

Standard

Standard

Deviation

Error

Median (nm)

N=1, 1:100

517.22

191.10

16.39%

464.40

N=1, 1:80

456.61

173.42

14.98%

413.15

N=1, 1:65

459.89

156.94

13.61%

446.90

N=2, 1:100

561.26

177.28

17.73%

551.70

N=2, 1:80

466.82

151.04

13.25%

452.60

N=2, 1:65

449.25

206.74

19.36%

374.45

N=1, 1:40,

602.87

221.62

21.84%

635.00

535.65

172.49

17.16%

495.00

559.60

266.50

40.64%

579.10

609.19

143.92

13.42%

613.55

Dean

N=2, 1:40,
Dean

N=1, 1:60,
Dean

N=2, 1:60,
Dean

3.3.3 Effect of Volume Ratio on Particle Size Under Batch Synthesis Conditions

For the batch synthesis studies, it was noted that as the volume ratio decreased the
average particle size decreased. On the other hand, the median platelet size decreased in

the n=2 thickness with volume ratio, while no such pattern was noted for the n=1 batch
synthesis thickness. The distribution plots for n=1 furthermore illustrated that a narrower

size distribution was obtained at smaller volume ratios. EDS analysis showed that an
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approximate 1:4 lead to iodide ratio was achieved in the n=1 nanoplatelets, and an
approximate 2:7 lead to iodide ratio for the n=2 nanoplatelets.

3.3.4 Effect of Flowrate on Particle Size Under Microfluidic Synthesis Conditions
On the microfluidic level, there was no definitive trend in the means within the

same thickness and the different flow rates; however, the n=2 nanoplatelets appeared to
have smaller means compared to their n=1 counterpart. No trend in the microfluidic
medians across the different thicknesses as well as the different flowrates was observed.

The microfluidic distribution plots illustrated in Figure 22 indicate that a narrower size

distribution was obtained from the n=2 nanoplatelets regardless of the flow rate ratios.
Similar to the batch EDS results, a more accurate lead to iodide ratio was acquired for both

n=1 and n=2 thicknesses on the microfluidic level.
There were experimental limitations at both the batch and microfluidic levels in terms

of the volume and flow rate ratios that could be tested. With the combination of compounds
used in the precursor fluid, and toluene chosen as the solvent, a volume ratio smaller than

1:65 for the batch synthesis level (precursor to toluene volume) could not be achieved. To
establish this lower limit, multiple trials conducted with the 1:60 (precursor to toluene

volume) ratio resulted in a pale-yellow color, indicating that the perovskite platelets were
not successfully synthesized. On the other hand, the flow rate range that could be tested on
the microfluidic platforms was dictated by the device itself. Due to the fluid characteristics,

toluene could not enter the device at a flow rate less than 20 times and more than 60 times
greater than that of the precursor fluid. Flow rate ratios outside of these bounds caused an

uneven distribution of pressure and resulted in a cracked device or excess fluid buildup in

either of the syringe delivery systems. In such instances, perovskite platelets were not
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successfully synthesized. Additionally, it was assumed that the reactions were not changing
or continuing once the product solution exited from the microfluidic device, although some

mechanism for stopping the potentially continued reaction may be studied in future
experiments.

3.3.5 Comparison of Microfluidic to Batch Synthesis
Overall, these experiments showed almost no significant differences in the average
particle size of perovskite platelets synthesized using batch versus microfluidic routes. This

is significant and relevant as future studies could use microfluidic devices (less volumes,

quick reactions, high-throughput) to test various operating conditions for such nanoplatelet
synthesis, without losing on the quality or size characteristics realized in batch
counterparts. A study conducted by Weidman et al., the first study in this field of lead

iodide perovskite platelet, discusses how n=1 and n=2 nanoplatelets from batch synthesis
route had relatively large lateral dimensions (100 nm to 1 pm), which promoted their self
assembly into stacked superlattice structures (Weidman et al., 2016). This is similar in
structure to what we noted in the current study from the SEM images. This wide range of

particle sizes in Weidman study resulted from nonsolvent crystallization at the bulk level,
while the microfluidic platforms utilized in this study led to an average platelet diameter

between 535 nm to 610 nm. Such narrow size distribution of platelets resulting from the
microfluidic synthesis could have applications where size homogeneity is desirable, and
enables us to explore models that describe how nanoplatelet nucleation, growth, and

ripening occurs in these experiments (Ott et al., 2017).
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CHAPTER IV
CONCLUSIONS

From the results of this study, it can be confirmed that the microfluidic passive

mixer platforms designed (and tested) by Joshua Clark and Brian Hama are indeed capable
for synthesizing nanoparticles of various types. Here, we synthesized three different types

of nanoparticles and optimized their synthesis conditions and characterized their sizes and
purity:

1. The synthesis of polymeric PLGA nanoparticles in a reverse SHB device showed
that the optimal operating conditions were: 0.15 wt% polymer composition, with
each fluid entering the device at 70 ^L/min. These conditions yielded reproducible

smallest average particle size and a tight size distribution, that would be helpful in
applications including drug encapsulation and release kinetics studies.
2. Gold nanoparticles synthesized in various types of Dean mixers showed that
smaller averages and tighter size distributions were achieved in the D4 and D5

mixers which have rectangular cross-sections, compared to MD4 and MD5

counterparts.

3. For perovskite nanoplatelets synthesis, we noted that the average particle size
decreased as the volume ratio decreased in batch synthesis route, while the n=2
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nanoplatelets appeared to have smaller average size and tighter distributions

compared to their n=1 counterparts in the microfluidic synthesis route. PNPs with
n=1 thickness synthesized in a D4 microfluidic device had spectrally narrower
emissions than PNPs of n=1 thickness synthesized with a batch process.

In each of the these cases, the microfluidic platforms showed comparable outcomes
or better outcomes over the batch synthesis processes. Synthesis at the microfluidic level
allowed for a more stable environment and control over reaction variables, leading to a

highly tunable and reproducible product. Control on polymeric nanoparticle size
uniformity and purity is beneficial for predictability in encapsulated drug delivery
applications, while such control on perovskite synthesis (stack size, shape, purity) is

beneficial for industrial applications (e.g., composites, additives). Finally, microfluidic

platforms are economically beneficial as they require less commodities (e.g., precious

reagents) and time.
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APPENDIX A: GOLD NANOPARTICLE GROWTH MECHANISM AND STABILITY

Figure A.1: The four-step gold nanoparticle growth mechanism of the Turkevich method.
The first step is a partial reduction of the gold precursor, allowing for small gold monomer
clusters to begin forming. These clusters continue to grow in the second step until they
identify as seed particles with a radius greater than 1.5 nm. Additionally, the gold ions that
remain become co-ions due to their attraction and then attachment to the electronic double
layer of the seed particles. At this point of the growth mechanism, all the particles have
been formed, indicating that the number of particles in this process remains constant after
a short initial phase. The third and fourth step mainly involve the reduction the ionic gold,
first at a slow pace and then developing into a more rapid pace. This thereby leads to the
generation of gold monomers (until the precursor is fully consumed) to grow exclusively
on top of the seed particles’ surfaces. The final particle size of the Turkevich synthesis
method is therefore dependent on the number of seed particles, determined by the amount
of gold monomers available for the seed particle formation and the seed particle size.
Reproduced by Wuithschick et al.
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Figure A.2: The concept of colloidal stability is demonstrated against reaction parameters
such as different species and temperature changes, along with the available thermal
energy. The colloidal stability is due to the result of attractive van der Waals and repulsive
electrostatic forces between two particles. By the DLVO theory, the sum of these opposing
forces leads to an interaction potential that is known as the aggregation barrier. This
aggregation barrier can therefore be quantified as the energy required for the two particles
to aggregate, further providing a direct measure of the colloidal stability. The general
trend shows that as the colloidal stability between the particles increases, so does the
particle size. Reproduced by Wuithschick et. al.
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APPENDIX B: MICROFLUIDIC DEVICE FABRICATION

Figure B.1: Visual representation of the reverse SHB microfluidic device fabrication
procedure detailed above. A) The SU-8 mold is clean and ready for use. B) The SU-8 mold
(left) is prepared for its first use with a silanizing agent (right). C) PDMS solution is
prepared and poured into the mold. D) The loaded mold is vacuumed to remove air
bubbles. E) After baking for two hours, the cured PDMS is cut out from the mold. F) A
biopsy punch is used to form the inlet and outlet ports. G) Adhesive tape is used to remove
dust and other particulates. H) The device is boiled to leech PDMS residues from the
surfaces. I) The device is bonded to a glass slide by treating the surface with plasma. J)
Closer view of plasma treatment. K) The treated PDMS is placed onto the treated glass
and allowed to laminate. L) After lightly pressing the PDMS to the glass, all air pockets
are removed. Image courtesy: Marissa Sarsfield, CSU Master’s student, Dr. Kothapalli
lab.
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APPENDIX C: DETAILS OF THE EXPERIMENTAL SETUP
Fabrication of Syringe Delivery System

Figure C.1: Images of the tubing system for the microfluidic device. (Lower Left) Overall
image of a tubing-syringe set. (Upper Left) Close up of the syringe. (Upper Right)
Connection between the larger and smaller tubing sizes. (Lower Right) Pipette tip
connected to the elbow joint and smaller tubing size. A syringe delivery system was
employed to transport the two fluids to the inlet ports of the device. The design involved a
10 mL syringe (Henke Sass Wolf, 10 mL Norm-Ject) with a %’’ inner diameter PVC tubing
(Clearflex 60) fixed at its end. Next, this tubing wasfixed onto a 1/16’’ inner diameter PVC
tubing (Clearflex 60), which was then connected to a 90° elbow joint (McMaster-Carr)
with a pipette tip attached. Epoxy glue was used to fix all parts of the syringe system
together, along with zip ties to ensure no fluid would leak out when the experiment was
running. Once this dried completely, the tip can be inserted into an inlet port for delivery.
A pipette tip attached to the 1/16’’ tubing was then used to collect productfrom the outlet
port. Image courtesy: Marissa Sarsfield, CSU Master’s student, Dr. Kothapalli lab.
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Figure C.2: Top: PicoPlus pump calibrations ; Bottom: Razel pump calibrations. Image
courtesy: Brian Hama, CSU Master’s student, Dr. Kothapalli lab.
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Experimental Setup

Figure C. 3: A) The experimental setup from a top down view. Provided by Hama et. al. B)
Demonstration of the pipette tips being inserted into their desired ports of the microfluidic
device. Image courtesy: Brian Hama, CSU Master’s student, Dr. Kothapalli lab.
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APPENDIX D: NANOPLATELET EDS DATA

Figure D. 1:Batch synthesis data. A&B) The EDS result page that shows the SEM image, spectra, and elemental composition
breakdown, confirming that the 1:65 n=2 has an approximate 2:7 lead iodide ratio. C&D) The EDS result page that shows the
SEM image, spectra, and elemental composition breakdown, confirming that the 1:80 n=2 has an approximate 2:7 lead iodide
ratio. E&F) The EDS result page that shows the SEM image, spectra, and elemental composition breakdown, confirming that
the 1:100 n=2 has an approximate 2:7 lead iodide ratio.
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Figure D.2: Microfluidic synthesis data: A&B) The EDS result page that shows the SEM
image, spectra, and elemental composition breakdown, confirming that the 1:40 n=1 has
an approximate 1:4 lead iodide ratio. C&D) The EDS result page that shows the SEM
image, spectra, and elemental composition breakdown, confirming that the 1:40 n=2 has
an approximate 2:7 lead iodide ratio.
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APPENDIX E: SPECTROMETRY VERIFICATION DATA

Figure E. 1: Additional absorption graphs generated by the NS3 to verify the peaks and
characteristics of lead iodide perovskite nanoplatelets, for the n=1 batch conditions.

Figure E. 2: Additional absorption graphs generated by the NS3 to verify the peaks and
characteristics of lead iodide perovskite nanoplatelets, for the n=1 batch conditions.
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APPENDIX F: ADDITIONAL SEM IMAGES

Figure F.1: Polymeric nanoparticle synthesis: A&B) SEM images from P2 condition that show further characteristics of the
polymeric nanoparticles synthesized. C&D) SEM images from P3 condition that show further characteristics of the polymeric
nanoparticles synthesized. E&F) SEM images from P4 condition that show further characteristics of the polymeric nanoparticles
synthesized.
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Figure F. 2: A&B) SEM images from P5 condition that show further characteristics of the polymeric nanoparticles synthesized.
C&D) SEM images from P6 condition that show further characteristics of the polymeric nanoparticles synthesized. E&F) SEM
images from P7 condition that show further characteristics of the polymeric nanoparticles synthesized.
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Figure F.3: Gold nanoparticle synthesis: A&B) SEM images from the Dean 4 device
condition that show further characteristics of the gold nanoparticles synthesized. C&D)
SEM images from the Modified Dean 4 device condition that show further characteristics
of the gold nanoparticles synthesized.
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Figure F.4: Gold nanoparticle synthesis: A&B) SEM images from the Dean 5 device
condition that show further characteristics of the gold nanoparticles synthesized. C&D)
SEM images from the Modified Dean 5 device condition that show further characteristics
of the gold nanoparticles synthesized.
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Figure F.5: Perovskite platelet synthesis in batch at n=1 conditions: A&B) SEM images from the 1:100 n=1 batch condition
that show further characteristics of the lead iodide perovskite nanoplatelets synthesized. C&D) SEM images from the 1:80 n=1
batch condition that show further characteristics of the lead iodide perovskite nanoplatelets synthesized. E&F) SEM images
from the 1:65 n=1 batch condition that show further characteristics of the lead iodide perovskite nanoplatelets synthesized.
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Figure F.6: Perovskite nanoparticle synthesis using batch route at n=2 conditions: A&B) SEM images from the 1:100 n=2 batch
condition that show further characteristics of the lead iodide perovskite nanoplatelets synthesized. C&D) SEM images from the
1:80 n=2 batch condition that show further characteristics of the lead iodide perovskite nanoplatelets synthesized. E&F) SEM
images from the 1:65 n=2 batch condition that show further characteristics of the lead iodide perovskite nanoplatelets
synthesized.
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Figure F.7: Perovskite synthesis in microfluidic platforms at n=1 conditions: A&B) SEM
images from the 1:40 n=1 microfluidic condition that show further characteristics of the
lead iodide perovskite nanoplatelets synthesized. C&D) SEM images from the 1:60 n=1
microfluidic condition that show further characteristics of the lead iodide perovskite
nanoplatelets synthesized.
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Figure F.8: Perovskite synthesis in microfluidic devices at n=2 conditions: A&B) SEM
images from the 1:40 n=2 microfluidic condition that show further characteristics of the
lead iodide perovskite nanoplatelets synthesized. C&D) SEM images from the 1:60 n=2
microfluidic condition that show further characteristics of the lead iodide perovskite
nanoplatelets synthesized.
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